Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis

Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis

<b>Background:</b> Interstitial lung diseases (ILDs) encompass a diverse group of disorders affecting the lung interstitium, leading to inflammation, fibrosis, and impaired respiratory function. Currently, the identification of new diagnostic and prognostic biomarkers for ILDs turns out...

Full description

Bibliographic Details
Main Authors: Piera Soccio, Giorgia Moriondo, Miriana d’Alessandro, Giulia Scioscia, Laura Bergantini, Sara Gangi, Pasquale Tondo, Maria Pia Foschino Barbaro, Paolo Cameli, Elena Bargagli, Donato Lacedonia
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Biomedicines
Subjects:
IPF
KL-6
progression
progressive fibrosis
non-progressive fibrosis
biomarkers
Online Access:https://www.mdpi.com/2227-9059/12/2/269

Internet

https://www.mdpi.com/2227-9059/12/2/269

Similar Items